Abstract

Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups. To date, three types of influenza vaccines have been licensed: inactivated, live-attenuated, and recombinant haemagglutinin vaccines. Effectiveness studies allow an assessment of the positive effects of influenza vaccines in the field. The effectiveness of current influenza is suboptimal, being estimated as 40% to 60% when the vaccines strains are antigenically well-matched with the circulating viruses. This review focuses on influenza viruses and vaccines and the role of vaccine effectiveness studies for evaluating the benefits of influenza vaccines. Overall, influenza vaccines are effective against morbidity and mortality in all age and risk groups, especially in young children and older adults. However, the effectiveness is dependent on several factors such as the age of vaccinees, the match between the strain included in the vaccine composition and the circulating virus, egg-adaptations occurring during the production process, and the subject's history of previous vaccination.

MeSH

Mortality, Vaccines, Vaccination, Influenza, Human, Viruses, Influenza Vaccines, Morbidity, Orthomyxoviridae

Cited by

• Adult influenza vaccination coverage before, during and after the COVID-19 pandemic in Canada. BMC Public Health, 2024
• Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond. Clin Microbiol Rev, 2024
• A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine. Microorganisms, 2024
• High-throughput 96-well plate-based porcine antibody isolation protocol. PLoS One, 2025
• Fast and flu-rious: How to prevent and treat emerging influenza A viruses. PLoS Pathog, 2025
• Online survey on barriers and drivers to flu vaccination among staff at a German university hospital during the Covid-19 pandemic 2022 (flu-vaccination motive study). GMS Hyg Infect Control, 2025
• Assessing barriers and facilitators of attitudes toward seasonal influenza vaccination among pregnant women using the Health Belief Model. Hum Vaccin Immunother, 2025
• Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities. Hum Vaccin Immunother, 2023
• Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals. Front Immunol, 2023
• Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses. Vaccines (Basel), 2023
• Immunogenicity of Inactivated H5 Avian Influenza Vaccine Used in Commercial Laying Pullet in Tehran Province, Iran. Arch Razi Inst, 2024
• Reduced risks of influenza-associated hospitalization and complications following vaccination among over 2 million older individuals: a nationwide study using target trial emulation framework. BMC Med, 2025
• Association between influenza vaccine effectiveness and chronic diseases among older adults with dementia. Sci Rep, 2025
• The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence. Hum Vaccin Immunother, 2023
• Double-layered protein nanoparticles conjugated with truncated flagellin induce improved mucosal and systemic immune responses in mice. Nanoscale Horiz, 2024
• Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern. Vaccines (Basel), 2025
• [Flu vaccination and value-based health care: operational solutions to safeguard public health]. J Prev Med Hyg, 2022
• Concepts and methods for predicting viral evolution. ArXiv, 2024
• Concepts and methods for predicting viral evolution. bioRxiv, 2024
• Knowledge, attitude, practice, and barriers among physicians in the Middle East and North Africa region toward influenza vaccination for the high-risk group of patients: a cross-sectional study. Trop Dis Travel Med Vaccines, 2025